Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
The lawsuits target a range of businesses that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.
The lawsuits target a range of businesses that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.
Read the full article on CNBC
Read Full Article →